Zimmer Biomet Holdings, Inc. – NYSE:ZBH
Zimmer Biomet Holdings stock price today
$104.31
-2.56
-2.4%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 3 hours
Zimmer Biomet Holdings stock price monthly change
-1.67%
month
Zimmer Biomet Holdings stock price quarterly change
-1.67%
quarter
Zimmer Biomet Holdings stock price yearly change
-11.77%
year
Zimmer Biomet Holdings key metrics
Market Cap | 21.22B |
Enterprise value | 27.27B |
P/E | 19.95 |
EV/Sales | 3.59 |
EV/EBITDA | 10.86 |
Price/Sales | 2.80 |
Price/Book | 1.74 |
PEG ratio | 0.09 |
EPS | 4.63 |
Revenue | 7.45B |
EBITDA | 2.38B |
Income | 963.9M |
Revenue Q/Q | 3.17% |
Revenue Y/Y | 4.85% |
Profit margin | 14.27% |
Oper. margin | 18.12% |
Gross margin | 66.29% |
EBIT margin | 18.12% |
EBITDA margin | 31.96% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeZimmer Biomet Holdings stock price history
Zimmer Biomet Holdings stock forecast
Zimmer Biomet Holdings financial statements
Average Price Target
$119.17
Potential upside: 14.24%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 1.86B | 209.6M | 11.21% |
|---|---|---|---|
| Sep 2023 | 1.75B | 162.7M | 9.28% |
| Dec 2023 | 1.94B | 419.2M | 21.61% |
| Mar 2024 | 1.88B | 172.4M | 9.13% |
0.67%
Yield TTM
| Payout ratio | 18.29% |
|---|
| 2019 | 0.66% |
|---|---|
| 2020 | 0.64% |
| 2021 | 0.78% |
| 2022 | 0.75% |
| 2023 | 0.79% |
| Jun 2023 | 21294300000 | 8.91B | 41.87% |
|---|---|---|---|
| Sep 2023 | 21217300000 | 8.69B | 41% |
| Dec 2023 | 21496900000 | 9.00B | 41.91% |
| Mar 2024 | 21452400000 | 8.84B | 41.24% |
| Jun 2023 | 347.9M | -243.1M | -109.4M |
|---|---|---|---|
| Sep 2023 | 337.6M | -165.6M | -196M |
| Dec 2023 | 588.4M | -220.8M | -251.4M |
| Mar 2024 | 228M | -195M | -50.1M |
Zimmer Biomet Holdings alternative data
| Sep 2023 | 18,000 |
|---|---|
| Oct 2023 | 18,000 |
| Nov 2023 | 18,000 |
| Dec 2023 | 18,000 |
| Jan 2024 | 18,000 |
| Feb 2024 | 18,000 |
| Mar 2024 | 18,000 |
| Apr 2024 | 18,000 |
| May 2024 | 18,000 |
| Jun 2024 | 18,000 |
| Jul 2024 | 18,000 |
Zimmer Biomet Holdings other data
89.57%
+1.13%
of ZBH is owned by hedge funds
931
-36
188.44M
+2.19M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2023 | 6171 | 0 |
| Nov 2023 | 2135 | 0 |
| Feb 2024 | 0 | 26156 |
| Mar 2024 | 0 | 1705 |
| May 2024 | 0 | 12857 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | VAN ZUILEN WILFRED officer: Group Pres, EMEA | Common Stock | 2,633 | N/A | N/A | ||
Option | VAN ZUILEN WILFRED officer: Group Pres, EMEA | Restricted Stock Units | 2,633 | N/A | N/A | ||
Option | STELLATO PAUL A officer: VP, Controller & CAO | Common Stock | 627 | N/A | N/A | ||
Option | STELLATO PAUL A officer: VP, Controller & CAO | Restricted Stock Units | 627 | N/A | N/A | ||
Sale | YI SANG officer: Group Pr.. | Common Stock | 12,857 | $114.69 | $1,474,582 | ||
Sale | YI SANG officer: Group Pr.. | Common Stock | 12,857 | $114.69 | $1,474,582 | ||
Option | WINKLER LORI officer: SVP and CHRO | Common Stock | 772 | N/A | N/A | ||
Option | WINKLER LORI officer: SVP and CHRO | Restricted Stock Units | 772 | N/A | N/A | ||
Option | YI SANG officer: Group Pr.. | Common Stock | 1,705 | $91.53 | $156,059 | ||
Option | YI SANG officer: Group Pr.. | Common Stock | 1,705 | $91.53 | $156,059 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 8 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
Smith & Nephew Getting No Credit For Self-Improvement Efforts ... But Should It?
Stock Picks From Seeking Alpha's December 2024 New Analysts
Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook
NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead
Zimmer Biomet: Brighter Prospects In H2 2024
U.S. Wide-Moat Stocks On Sale - The May 2024 Heat Map
U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map
U.S. Wide-Moat Stocks On Sale - The February 2024 Heat Map
Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
-
What's the price of Zimmer Biomet Holdings stock today?
One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $104.31.
-
When is Zimmer Biomet Holdings's next earnings date?
Unfortunately, Zimmer Biomet Holdings's (ZBH) next earnings date is currently unknown.
-
Does Zimmer Biomet Holdings pay dividends?
Yes, Zimmer Biomet Holdings pays dividends and its trailing 12-month yield is 0.67% with 18% payout ratio. The last Zimmer Biomet Holdings stock dividend of $0.24 was paid on 31 Jan 2022.
-
How much money does Zimmer Biomet Holdings make?
Zimmer Biomet Holdings has a market capitalization of 21.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.55% to 7.39B US dollars.
-
What is Zimmer Biomet Holdings's stock symbol?
Zimmer Biomet Holdings, Inc. is traded on the NYSE under the ticker symbol "ZBH".
-
What is Zimmer Biomet Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Zimmer Biomet Holdings?
Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Zimmer Biomet Holdings's key executives?
Zimmer Biomet Holdings's management team includes the following people:
- Mr. Bryan C. Hanson Chairman, Pres & Chief Executive Officer(age: 58, pay: $3,030,000)
- Mr. Ivan Tornos Group Pres of Global Bus.es, The Americas & EMEA Region and Chief Operating Officer(age: 49, pay: $1,490,000)
- Mr. Suketu P. Upadhyay Executive Vice President & Chief Financial Officer(age: 56, pay: $1,340,000)
- Mr. Sang Yi Group Pres of Asia Pacific(age: 63, pay: $1,220,000)
-
How many employees does Zimmer Biomet Holdings have?
As Jul 2024, Zimmer Biomet Holdings employs 18,000 workers.
-
When Zimmer Biomet Holdings went public?
Zimmer Biomet Holdings, Inc. is publicly traded company for more then 24 years since IPO on 25 Jul 2001.
-
What is Zimmer Biomet Holdings's official website?
The official website for Zimmer Biomet Holdings is zimmerbiomet.com.
-
Where are Zimmer Biomet Holdings's headquarters?
Zimmer Biomet Holdings is headquartered at 345 East Main Street, Warsaw, IN.
-
How can i contact Zimmer Biomet Holdings?
Zimmer Biomet Holdings's mailing address is 345 East Main Street, Warsaw, IN and company can be reached via phone at +57 4 2676131.
-
What is Zimmer Biomet Holdings stock forecast & price target?
Based on 5 Wall Street analysts` predicted price targets for Zimmer Biomet Holdings in the last 12 months, the avarage price target is $119.17. The average price target represents a 14.24% change from the last price of $104.31.
Zimmer Biomet Holdings company profile:
Zimmer Biomet Holdings, Inc.
zimmerbiomet.comExchange:
NYSE
Full time employees:
18,000
Industry:
Medical - Devices
Sector:
Healthcare
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
345 East Main Street
Warsaw, IN 46580
Warsaw, IN 46580
CIK: 0001136869
ISIN: US98956P1021
CUSIP: 98956P102
